Grids to aid breast cancer diagnosis and research

December 07, 2005

The MammoGrid project is studying the commercial possibilities for its distributed computing environment that employs existing Grid technologies for the creation of a European database of mammogram data. By using Grid computing, the system allows hospitals, healthcare workers and researchers to share data and resources. It supports effective co-working, such as obtaining second opinions that reduce the risk of misdiagnosis, and opens the door to powerful statistical analysis of the incidence and forms of breast cancer to assist future research.

"Breast cancer is one of many diseases that is complicated to diagnose and for which Grid computing will prove to be a very valuable tool," says Jean-Marie Le Goff, head of the Technology Transfer Service at CERN.

Breast cancer screening procedures suffer from several complications including the physical differences between the breasts of different women, the different procedures and equipment used to obtain mammography images, and the large amount of image data produced that makes computer-aided diagnosis (CAD) processing intensive.

These problems have contributed to the relatively high error rate of breast cancer screening procedures. It is estimated that around 30 per cent of mammograms result in either false positive diagnoses, whereby women are falsely diagnosed with breast cancer leading to unnecessary and painful biopsy, or, more seriously, in false negative diagnoses that lead to tumours going undetected.

With one in eight women developing breast cancer at some point in their lives and one in 28 dying from it, the importance of improving screening procedures and ensuring accurate diagnosis is evident.

By giving healthcare professionals the ability to use Grid computing to efficiently share data and resources their ability to accurately diagnose breast cancer is greatly enhanced. "A doctor in a small village, for example, probably doesn't have access to powerful tools but with Grid computing he can provide the patient with an analysis from a hospital online. Also if cancer is detected the doctor would be able to monitor data from mammography exams taken over the course of months to determine the patient's response to treatment," notes Le Goff.

The interconnectivity the system provides between different hospitals and medical centres makes obtaining a second opinion simpler and faster, opening the door to tele-diagnosis and the creation of communities of medical 'virtual organisations' able to co-work using the shared resources of the Grid. Analysis of mammograms can be carried out in different locations using CAD tools, for example.

The resource-boosting properties of Grid computing are particularly important for creating a European distributed mammography database that would give healthcare professionals access to millions of mammography images to assist diagnosis and research.

Such a database would not only improve diagnosis through enhancing comparative analysis with other breast cancer cases, but would provide important statistical information about the epidemiology of the disease.

The project developed a proof-of-concept demonstrator to test their Grid architecture that so far allows access to 30,000 mammogram images. Grid boxes were set up and used by clinicians at hospitals in Cambridge in the United Kingdom and at Udine in Italy as well as by researchers at Oxford University with CERN acting as the central node.

The project's success has led to interest from outside companies, with one Spanish firm, Helide, looking to deploy a commercial variant of the system in the region of Extremadura within a year.

"Helide is aiming to have a number of Grid boxes throughout the region that will enhance the ability of doctors to verify test results and obtain a second opinion and use of the clinical experience acquired by the Hospitals involved in the project. They then aim to scale it up in terms of what the system can do and the geographical area where it is used, expanding it to other areas of Spain and then Europe," Le Goff says.
-end-
Contact:
Jose Galvez / Jean-Marie Le Goff
CERN
Switzerland
Tel: +41-22-7679381 / +41-22-7678444
Email: Jose.Galvez@cern.ch/ Jean-Marie.Le.Goff@cern.ch
MammoGrid project website http://mammogrid.vitamib.com/


IST Results

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.